Psychosis
Dopamine Partial Agonist:
Ariprazole
Indication: Manage and treat schizophrenia and bipolar disorder, as well as for the treatment of irritability associated with autistic disorder.
Pharmaco-kinetics:
Absorption: peak plasma concentrations occurring within 3-5hrsafter oral administration, with a bioavailability of approximately 87%. Metabolism involves hepatic pathways, primarily through the CYP2D6 and CYP3A4 enzyme systems.
distribution: intravenous administration is high (404L or 4.9L/kg) with a significant volume of distribution in various tissues, indicating extensive tissue binding and potential accumulation in the body.
Metabolism: metabolized by 3 bio transformation pathways: dehydrogenation, hydroxylation, and N-dealkylation , each contributing to the formation of several active metabolites that may enhance or prolong the therapeutic effects.
excretion:
Pharmaco-dynamics:
Adverse reactions: Constipation, dry mouth, dizziness, and increased heart rate, which may vary in severity among individuals. Myalgia
Nursing Considerations:
Brexpiprazole
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Cariprazine
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Dopamine-serotonin receptor blockers:
Chlopromazine
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Pericyazine
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Triflupenthixol
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Flupenthixol deconoate
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Dopamine Receptor Blockers
Haloperidol
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations:
Amisulpride
Indication
Pharmaco-kinetics:
Pharmaco-dynamics:
Adverse reactions:
Nursing Considerations: